Amanda Dalby

1 - 6 out of 6Page size: 10

Publications

  1. 2020
  2. Published

    Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions

    Amanda Dalby, Jeremy Pike, Neil Morgan & Steve Watson, 14 Jul 2020, In: Blood Advances. 4, 13, p. 2953–2961 9 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2019
  4. Published

    Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling

    Amanda Dalby, 22 Aug 2019, In: Arteriosclerosis, Thrombosis, and Vascular Biology. 39, 11, p. 2289–2302

    Research output: Contribution to journal › Article › peer-review

  5. 2018
  6. Published

    Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision

    Amanda Dalby, 11 Dec 2018, In: Stem Cell Reports. 11, 6, p. 1462-1478

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Anagrelide is an anti-megakaryocytic and not an anti-platelet agent

    Steve Watson & Amanda Dalby, 7 Nov 2018, In: Platelets. p. 136-137

    Research output: Contribution to journal › Review article › peer-review

  8. E-pub ahead of print

    Mutation in GNE is associated with a Severe Form of Congenital Thrombocytopenia

    Amanda Dalby, Gillian Lowe, Steve Watson & Neil Morgan, 25 Jun 2018, In: Blood.

    Research output: Contribution to journal › Letter › peer-review

  9. 2016
  10. Published

    Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming

    Amanda Dalby, Tatyana Ponomaryov, Alexander Brill & 2 others, , 1 Sep 2016, In: Nature Communications. 7, 1, 16 p., 11208.

    Research output: Contribution to journal › Article › peer-review